GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 827 filers reported holding GLAXOSMITHKLINE PLC in Q2 2022. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $69,000 | -54.3% | 1,585 | -54.2% | 0.02% | -51.3% |
| Q1 2022 | $151,000 | -2.6% | 3,459 | -1.7% | 0.04% | +2.6% |
| Q4 2021 | $155,000 | +496.2% | 3,520 | +412.4% | 0.04% | +245.5% |
| Q3 2021 | $26,000 | -76.1% | 687 | -75.0% | 0.01% | -64.5% |
| Q2 2021 | $109,000 | +62.7% | 2,744 | +47.2% | 0.03% | +34.8% |
| Q1 2021 | $67,000 | +131.0% | 1,864 | +134.5% | 0.02% | +4.5% |
| Q4 2020 | $29,000 | – | 795 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
| KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
| Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
| Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
| CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
| PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
| Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
| Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
| EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
| Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |